Class 4 Caution in Use
Bausch & Lomb UK limited has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
---|---|---|---|
3849221 | EMERADE 150 AUTO-INJECTOR | BAUSCH & LOMB UK | ALL STOCK |
3849239 | EMERADE 300 AUTO-INJECTOR | BAUSCH & LOMB UK | ALL STOCK |
3849247 | EMERADE 500 AUTO-INJECTOR | BAUSCH & LOMB UK | ALL STOCK |
Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.
For stock enquiries please contact Bausch & Lomb Customer Services: Tel: 0208 781 2991 Email: Pharma_CS@bausch.com.
For medical information enquiries please contact Lizanne Kombrink, Pharmacovigilance and Medical Information Officer: Tel: 0208 781 5523 Email: Pharmacovigilance.UK@bausch.com.
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
If you have any questions, then please contact your local Service Centre Customer Services team.